Reuters logo
BRIEF-Cosmo Pharmaceuticals FY operating revenues up 11.6 pct at 67.7 million euros
March 24, 2017 / 6:05 AM / 8 months ago

BRIEF-Cosmo Pharmaceuticals FY operating revenues up 11.6 pct at 67.7 million euros

March 24 (Reuters) - Cosmo Pharmaceuticals NV:

* FY operating revenues increased by 11.6 pct to 67.7 million euros ($72.89 million)

* FY profit after tax of 19.3 million euros (2015 results were primarily driven by 257.8 million euros gain on sale of Cassiopea shares)

* A dividend payment of 1.5 euros/share will be proposed at next AGM on May 24, 2017

* While there are some timing uncertainties, Cosmo expects to post another excellent year in 2017 Source text for Eikon: Further company coverage: ($1 = 0.9288 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below